225 related articles for article (PubMed ID: 6175310)
21. [Plasma neuropeptide Y (NPY) levels in patients with gastric and colorectal carcinomas].
Li Y; Chen S; Li Z
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):213-5. PubMed ID: 10921011
[TBL] [Abstract][Full Text] [Related]
22. [Assay of "pregnancy alpha 2 glycoprotein" in the serum of prostatic cancer patients and changes during estrogen therapy].
Lanson Y; Lanson M; Gutman N; Muh JP
J Urol Nephrol (Paris); 1979 Jun; 85(6):399-407. PubMed ID: 90738
[TBL] [Abstract][Full Text] [Related]
23. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
[TBL] [Abstract][Full Text] [Related]
24. The biological and clinical significance of tumor markers in tissue extracts.
Castelli M; Sega FM; Sciarretta F; Casale V; Coloni F; Sega E
Cancer Detect Prev; 1983; 6(1-2):61-6. PubMed ID: 6883394
[TBL] [Abstract][Full Text] [Related]
25. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
26. [Serum concentration of pregnancy-associated alpha 2-glycoprotein in cervical cancer (author's transl)].
Tatra G
Wien Klin Wochenschr; 1980 Apr; 92(9):314-7. PubMed ID: 6156547
[TBL] [Abstract][Full Text] [Related]
27. [Pregnancy-associated alpha 2-glycoprotein (importance of its determination in malignant tumors)].
Bohn H; Bauer HW
Ric Clin Lab; 1981; 11 Suppl 2():65-72. PubMed ID: 7323618
[No Abstract] [Full Text] [Related]
28. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
29. Copper, zinc and superoxide dismutase in precancerous, benign diseases and gastric, colorectal and breast cancer.
Magálová T; Bella V; Brtková A; Beno I; Kudlácková M; Volkovová K
Neoplasma; 1999; 46(2):100-4. PubMed ID: 10466433
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in pregnant, estrogen-treated and breast cancer-bearing rats.
Sarcione EJ; Delluomo DS
Oncodev Biol Med; 1981; 2(5):345-54. PubMed ID: 7329816
[TBL] [Abstract][Full Text] [Related]
31. [Pregnancy protein-1 in the serum of patients with diseases of the breast].
Strache RR; Briese V; Szabo DG; Than GN; Kunze M; Richter D
Zentralbl Gynakol; 1987; 109(5):274-9. PubMed ID: 3035827
[TBL] [Abstract][Full Text] [Related]
32. Pregnancy-associated glycoprotein (alpha 2-PAG)--a possible marker in breast cancer?
Wilking N; Carlström K; Gustafsson SA; Karnström L; von Schoultz B
Int J Cancer; 1984 Oct; 34(4):479-81. PubMed ID: 6208153
[TBL] [Abstract][Full Text] [Related]
33. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
34. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer].
Kovcić V; Jelić S; Filipović I; Tomasević Z
Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404
[TBL] [Abstract][Full Text] [Related]
35. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
36. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
[TBL] [Abstract][Full Text] [Related]
37. [Does an obturation in colorectal cancer also modify the behavior of the serum CEA level?].
Wedell J; Meyer zu Eissen P; Muchow U; van Calker H; Baginski B; Schlipköter HW
Zentralbl Chir; 1983; 108(15):967-73. PubMed ID: 6637204
[TBL] [Abstract][Full Text] [Related]
38. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
39. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.
Coban S; Yüksel O; Koçkar MC; Köklü S; Basar O; Tutkak H; Ormeci N
Hepatogastroenterology; 2007; 54(77):1472-6. PubMed ID: 17708279
[TBL] [Abstract][Full Text] [Related]
40. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
